Evaluation of integrated color-coded perfusion analysis for contrast-enhanced ultrasound (CEUS) after percutaneous interventions for malignant liver lesions: First results

Wiesinger, I and Beyer, L. P. and Zausig, N. and Verloh, N. and Wiggermann, P. and Stroszczynski, C. and Jung, E. M. (2018) Evaluation of integrated color-coded perfusion analysis for contrast-enhanced ultrasound (CEUS) after percutaneous interventions for malignant liver lesions: First results. CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 69 (1-2). pp. 59-67. ISSN 1386-0291, 1875-8622

Full text not available from this repository. (Request a copy)

Abstract

BACKGROUND: With the rising number of percutaneous ablation therapies in malignant liver lesions there is a need of reliable diagnostics after the intervention to differentiate between reactive changes and tumor. PURPOSE: To assess the success of percutaneous ablation therapies for malignant liver lesions using CEUS with perfusion analysis. MATERIAL AND METHODS: Retrospective analysis of perfusion analysis for 67 patients with 94 malignant liver lesions, treated with ablation therapies. The lesions were 70 hepatocellular carcinomas (HCC), 18 metastases, 4 cholangiocellular carcinomas (CCC), 2 lesions remained unclear. CEUS was performed after bolus injection of 1.6-2.4 ml of sulfur-hexafluoride microbubbles. The perfusion analysis was calculated using Peak, TTP, mTT and AUC with integrated software during the late arterial to early portal-venous phase for approximately 9 sec (5-15 sec). For the evaluation of the success after percutaneous treatment the perfusion results were compared to the follow-up control after 6 months with CT and MRI and CEUS. RESULTS: Perfusion analyses after percutaneous treatment of malignant liver lesions showed highly significant perfusion differences when comparing the center to the surrounding tissue and the margins (p < 0.0001) for Peak and also for AUC. 62 lesions were successfully treated, meaning there was no local recurrence after 6 months. In cases of residual tumor CEUS showed a nodular marginal enhancement, the corresponding perfusion analyses showed nodular red and yellow pseudo-color shades. CONCLUSIONS: Using CEUS and perfusion analysis, a critical analysis of post-ablation defects in malignant liver lesions is possible. With the help of pseudo-colors, remaining tumor-vascularization can be detected.

Item Type: Article
Uncontrolled Keywords: HEPATOCELLULAR-CARCINOMA; RADIOFREQUENCY ABLATION; EFSUMB GUIDELINES; CLINICAL-PRACTICE; DCE-US; PART 2; MULTICENTER; RECOMMENDATIONS; METASTASES; DIAGNOSIS; Ultrasound; ablation procedures; liver; perfusion
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Röntgendiagnostik
Depositing User: Dr. Gernot Deinzer
Date Deposited: 20 Mar 2020 13:36
Last Modified: 20 Mar 2020 13:36
URI: https://pred.uni-regensburg.de/id/eprint/15371

Actions (login required)

View Item View Item